| The immune contexture in human tumours: impact on clinical outcome WH Fridman, F Pagès, C Sautès-Fridman, J Galon Nature Reviews Cancer 12 (4), 298-306, 2012 | 5105 | 2012 |
| Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression E Becht, NA Giraldo, L Lacroix, B Buttard, N Elarouci, F Petitprez, J Selves, ... Genome biology 17, 1-20, 2016 | 2492 | 2016 |
| The immune contexture in cancer prognosis and treatment WH Fridman, L Zitvogel, C Sautès–Fridman, G Kroemer Nature reviews Clinical oncology 14 (12), 717-734, 2017 | 1909 | 2017 |
| B cells and tertiary lymphoid structures promote immunotherapy response BA Helmink, SM Reddy, J Gao, S Zhang, R Basar, R Thakur, K Yizhak, ... Nature 577 (7791), 549-555, 2020 | 1868 | 2020 |
| Guidelines for the use of flow cytometry and cell sorting in immunological studies A Cossarizza, HD Chang, A Radbruch, A Acs, D Adam, S Adam‐Klages, ... European journal of immunology 49 (10), 1457-1973, 2019 | 1850 | 2019 |
| B cells are associated with survival and immunotherapy response in sarcoma F Petitprez, A de Reyniès, EZ Keung, TWW Chen, CM Sun, J Calderaro, ... Nature 577 (7791), 556-560, 2020 | 1464 | 2020 |
| Immune infiltration in human tumors: a prognostic factor that should not be ignored J Galon, MC Dieu-Nosjean, E Tartour, C Sautes-Fridman, WH Fridman Oncogene 29 (8), 1093-1102, 2010 | 1345 | 2010 |
| Tertiary lymphoid structures in the era of cancer immunotherapy C Sautès-Fridman, F Petitprez, J Calderaro, WH Fridman Nature Reviews Cancer 19 (6), 307-325, 2019 | 1226 | 2019 |
| Presence of B cells in tertiary lymphoid structures is associated with a protective immunity in patients with lung cancer C Germain, S Gnjatic, F Tamzalit, S Knockaert, R Remark, J Goc, ... American journal of respiratory and critical care medicine 189 (7), 832-844, 2014 | 718 | 2014 |
| Dendritic cells in tumor-associated tertiary lymphoid structures signal a Th1 cytotoxic immune contexture and license the positive prognostic value of infiltrating CD8+ T cells J Goc, C Germain, TKD Vo-Bourgais, A Lupo, C Klein, S Knockaert, ... Cancer research 74 (3), 705-715, 2014 | 616 | 2014 |
| Classification of current anticancer immunotherapies L Galluzzi, E Vacchelli, JM Bravo-San Pedro, A Buqué, L Senovilla, ... Oncotarget 5 (24), 12472, 2014 | 574 | 2014 |
| Immune and stromal classification of colorectal cancer is associated with molecular subtypes and relevant for precision immunotherapy E Becht, A de Reyniès, NA Giraldo, C Pilati, B Buttard, L Lacroix, J Selves, ... Clinical cancer research 22 (16), 4057-4066, 2016 | 564 | 2016 |
| The clinical role of the TME in solid cancer NA Giraldo, R Sanchez-Salas, JD Peske, Y Vano, E Becht, F Petitprez, ... British journal of cancer 120 (1), 45-53, 2019 | 546 | 2019 |
| Tertiary lymphoid structures in cancer and beyond MC Dieu-Nosjean, J Goc, NA Giraldo, C Sautès-Fridman, WH Fridman Trends in immunology 35 (11), 571-580, 2014 | 532 | 2014 |
| Profound coordinated alterations of intratumoral NK cell phenotype and function in lung carcinoma S Platonova, J Cherfils-Vicini, D Damotte, L Crozet, V Vieillard, P Validire, ... Cancer research 71 (16), 5412-5422, 2011 | 523 | 2011 |
| The structure of a human type III Fcγ receptor in complex with Fc S Radaev, S Motyka, WH Fridman, C Sautes-Fridman, PD Sun Journal of Biological Chemistry 276 (19), 16469-16477, 2001 | 515 | 2001 |
| Interleukin-17 inhibits tumor cell growth by means of a T-cell–dependent mechanism F Benchetrit, A Ciree, V Vives, G Warnier, A Gey, C Sautès-Fridman, ... Blood, The Journal of the American Society of Hematology 99 (6), 2114-2121, 2002 | 496 | 2002 |
| Prognostic and predictive impact of intra-and peritumoral immune infiltrates WH Fridman, J Galon, F Pagès, E Tartour, C Sautès-Fridman, G Kroemer Cancer research 71 (17), 5601-5605, 2011 | 466 | 2011 |
| Orchestration and prognostic significance of immune checkpoints in the microenvironment of primary and metastatic renal cell cancer NA Giraldo, E Becht, F Pages, G Skliris, V Verkarre, Y Vano, A Mejean, ... Clinical Cancer Research 21 (13), 3031-3040, 2015 | 461 | 2015 |
| The tumor microenvironment in the response to immune checkpoint blockade therapies F Petitprez, M Meylan, A de Reyniès, C Sautès-Fridman, WH Fridman Frontiers in immunology 11, 784, 2020 | 447 | 2020 |
